Eliot Engel: “To me, diseases like muscular dystrophy are why the accelerated approval pathway is so important.”

I particularly want to thank Chairman Engel for his leadership, as well as the whole committee, for making the Caesar Act a reality.

I introduced the Caesar Syria Civilian Protection Act several years ago as a response to what we saw in this room.

Why have there been no designations by us of Russian companies and individuals who are so clearly and shamelessly giving Assad a lifeline?

I think that is scandalous and I think it, frankly, undermines whatever policy we are pursuing in Syria.